What Makes Axa (AXAHY) a New Strong Buy Stock

13.09.24 18:00 Uhr

Werte in diesem Artikel
Aktien

35,04 EUR 0,15 EUR 0,43%

Indizes

7.574,1 PKT 32,5 PKT 0,43%

514,5 PKT 2,3 PKT 0,45%

4.994,0 PKT 23,7 PKT 0,48%

1.492,7 PKT 8,1 PKT 0,54%

3.519,6 PKT -17,6 PKT -0,50%

7.709,4 PKT 3,2 PKT 0,04%

5.739,3 PKT 26,2 PKT 0,46%

4.482,7 PKT 24,0 PKT 0,54%

Investors might want to bet on Axa Sa (AXAHY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for Axa basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.For Axa, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>.Earnings Estimate Revisions for AxaThis company is expected to earn $3.85 per share for the fiscal year ending December 2024, which represents a year-over-year change of 7.5%.Analysts have been steadily raising their estimates for Axa. Over the past three months, the Zacks Consensus Estimate for the company has increased 1.8%.Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of 'buy' and 'sell' ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a 'Strong Buy' rating and the next 15% get a 'Buy' rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.You can learn more about the Zacks Rank here >>>The upgrade of Axa to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Axa Sa (AXAHY): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf AXA

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AXA

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu AXA S.A.

Analysen zu AXA S.A.

DatumRatingAnalyst
19.09.2024AXA OverweightBarclays Capital
18.09.2024AXA NeutralGoldman Sachs Group Inc.
04.09.2024AXA BuyJefferies & Company Inc.
04.09.2024AXA OverweightBarclays Capital
22.08.2024AXA BuyUBS AG
DatumRatingAnalyst
19.09.2024AXA OverweightBarclays Capital
04.09.2024AXA BuyJefferies & Company Inc.
04.09.2024AXA OverweightBarclays Capital
22.08.2024AXA BuyUBS AG
16.08.2024AXA BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
18.09.2024AXA NeutralGoldman Sachs Group Inc.
07.09.2022AXA NeutralUBS AG
03.08.2022AXA NeutralUBS AG
01.07.2022AXA NeutralJP Morgan Chase & Co.
01.07.2022AXA NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
10.05.2017AXA VerkaufenDZ BANK
02.08.2016AXA UnderperformMacquarie Research
23.01.2015AXA UnderweightJP Morgan Chase & Co.
12.01.2015AXA UnderweightJP Morgan Chase & Co.
19.11.2014AXA UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für AXA S.A. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"